Kam Siu

1.3k total citations · 1 hit paper
10 papers, 1.0k citations indexed

About

Kam Siu is a scholar working on Molecular Biology, Organic Chemistry and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kam Siu has authored 10 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kam Siu's work include Protein Degradation and Inhibitors (5 papers), Ubiquitin and proteasome pathways (3 papers) and Prostate Cancer Treatment and Research (3 papers). Kam Siu is often cited by papers focused on Protein Degradation and Inhibitors (5 papers), Ubiquitin and proteasome pathways (3 papers) and Prostate Cancer Treatment and Research (3 papers). Kam Siu collaborates with scholars based in United States and Japan. Kam Siu's co-authors include Andrew P. Crew, Hanqing Dong, James D. Winkler, Kevin Coleman, Craig M. Crews, Jing Wang, Kanak Raina, Yimin Qian, Jing Lü and Martha Altieri and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Kam Siu

10 papers receiving 992 citations

Hit Papers

PROTAC-induced BET protein degradation as a therapy for c... 2016 2026 2019 2022 2016 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kam Siu United States 8 883 304 274 132 49 10 1.0k
Octovia Monteiro United Kingdom 14 904 1.0× 205 0.7× 360 1.3× 134 1.0× 28 0.6× 15 1.1k
Duncan A. Hay United Kingdom 12 705 0.8× 122 0.4× 310 1.1× 194 1.5× 20 0.4× 18 938
Keith R. Hornberger United States 15 805 0.9× 371 1.2× 89 0.3× 405 3.1× 51 1.0× 18 1.2k
Mariell Pettersson Sweden 9 571 0.6× 280 0.9× 125 0.5× 84 0.6× 20 0.4× 13 706
Tomoya Sameshima Japan 15 749 0.8× 268 0.9× 170 0.6× 96 0.7× 31 0.6× 25 888
Tianfeng Xu China 19 1.1k 1.2× 536 1.8× 276 1.0× 226 1.7× 207 4.2× 30 1.3k
Momar Toure United States 14 2.0k 2.3× 889 2.9× 658 2.4× 178 1.3× 73 1.5× 18 2.2k
Juiwanna Kushner United States 22 697 0.8× 140 0.5× 228 0.8× 389 2.9× 42 0.9× 31 1.1k
Matthias Brand Germany 11 832 0.9× 379 1.2× 150 0.5× 48 0.4× 58 1.2× 29 977

Countries citing papers authored by Kam Siu

Since Specialization
Citations

This map shows the geographic impact of Kam Siu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kam Siu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kam Siu more than expected).

Fields of papers citing papers by Kam Siu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kam Siu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kam Siu. The network helps show where Kam Siu may publish in the future.

Co-authorship network of co-authors of Kam Siu

This figure shows the co-authorship network connecting the top 25 collaborators of Kam Siu. A scholar is included among the top collaborators of Kam Siu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kam Siu. Kam Siu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Crew, Andrew P., Kanak Raina, Hanqing Dong, et al.. (2017). Identification and Characterization of Von Hippel-Lindau-Recruiting Proteolysis Targeting Chimeras (PROTACs) of TANK-Binding Kinase 1. Journal of Medicinal Chemistry. 61(2). 583–598. 195 indexed citations
2.
Raina, Kanak, Jing Lü, Yimin Qian, et al.. (2016). PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer. Proceedings of the National Academy of Sciences. 113(26). 7124–7129. 661 indexed citations breakdown →
3.
Neklesa, Taavi K., Meizhong Jin, Andrew P. Crew, et al.. (2016). ARV-330: Androgen receptor PROTAC degrader for prostate cancer.. Journal of Clinical Oncology. 34(2_suppl). 267–267. 11 indexed citations
4.
Winkler, James D., Meizhong Jin, Ryan R. Willard, et al.. (2015). Abstract PR08: ARV-330: An androgen receptor PROTAC degrader for prostate cancer. Molecular Cancer Therapeutics. 14(12_Supplement_2). PR08–PR08. 1 indexed citations
5.
Jin, Meizhong, James D. Winkler, Kevin Coleman, et al.. (2015). Abstract LB-097: Targeted degradation of the androgen receptor in prostate cancer. Cancer Research. 75(15_Supplement). LB–97. 1 indexed citations
6.
Jin, Meizhong, Kam Siu, Earl W. May, et al.. (2013). Discovery of Novel Insulin-Like Growth Factor-1 Receptor Inhibitors with Unique Time-Dependent Binding Kinetics. ACS Medicinal Chemistry Letters. 4(7). 627–631. 14 indexed citations
7.
Jin, Meizhong, Prafulla C. Gokhale, Kenneth W. Foreman, et al.. (2010). Potent and selective cyclohexyl-derived imidazopyrazine insulin-like growth factor 1 receptor inhibitors with in vivo efficacy. Bioorganic & Medicinal Chemistry Letters. 21(4). 1176–1180. 13 indexed citations
8.
Li, An‐Hu, David B. Beard, Heather Coate, et al.. (2010). One-Pot Friedländer Quinoline Synthesis: Scope and Limitations. Synthesis. 2010(10). 1678–1686. 32 indexed citations
9.
Li, An‐Hu, Xin Chen, Matthew Cox, et al.. (2006). A highly effective one-pot synthesis of quinolines from o-nitroarylcarbaldehydes. Organic & Biomolecular Chemistry. 5(1). 61–64. 72 indexed citations
10.
Siu, Kam, et al.. (2005). Conformational dynamics of Cu(i) complexes of tripodal ligands: steric control of molecular motion. New Journal of Chemistry. 29(9). 1147–1147. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026